Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of Evorpacept (ALX148) With Azacitidine for Higher Risk Myelodysplastic Syndrome (ASPEN-02)

Myelodysplastic Syndrome

This Phase 1 / 2 clinical study will evaluate evorpacept (ALX148) in combination with azacitidine for the treatment of patients with higher risk myelodysplastic syndrome (MDS).
Myelodysplastic Syndrome
I/II
Byrne, Michael
NCT04417517
VICCHEMP2084

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: